Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

Rapamycin treatment significantly decreases induction of lytic KSHV proteins. by Lisa A. Nichols (357612)

Mean change in incidence and diagnoses if testing rates decrease. by Richard T. Gray (282417)

Level of phosphorylated syndecan-4 regulates NFAT activation and is decreased by calcineurin. by Alexandra V. Finsen (193861)

Mean-difference plots by country: Countries with decreased variance and decreased mean height (95% confidence interval shaded). by Jewel Gausman (5210969)

WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription. by Sandrine L. Anne (489755)

“…(<i>F</i>) After 24 h of GLI1 overexpression in GCPs, <i>Gli2</i>, and <i>Ptch1</i> mRNA levels increase in the control condition (Gli1=464±119, Gli2=2.04±0.25, <i>Ptch1</i>=1.59±0.14) and this effect is inhibited in the presence of WNT3 (Gli1=314±166, Gli2=1.14±0.3, <i>Ptch1</i>=0.71±0.12). …”

Female ρ1 (−/−) mice showed decreased ethanol conditioned taste aversion. by Yuri A. Blednov (396502)

HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…[NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”

RhoC knockdown decrease cellular migration and is rescued by ectopic RhoC overexpression. by Ningfeng Fiona Li (492081)

Compatible pollen triggers a decrease in S-RNase transcript levels by a post-transcriptional mechanism. by Bolin Liu (59887)

Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches). by Anjuman Arora (750291)

Subjects:

GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

“…GCase activity measured by MDW941 in brain (C) measured as follows: WT 4mo 15.54±0.13, HOM 4mo 1.33±0.04, WT 8mo 15.99±0.23, HOM 8mo 1.36±0.02, WT 12 mo 18.61±0.24, HOM 12mo 2.37±0.02. GCase activity measured by MDW941 in liver (D) measured as follows: WT 4mo 59.48±3.14, HOM 4mo 2.15±0.10, WT 8mo 69.27±2.36, HOM 8mo 2.03±0.13, WT 12 mo 79.14±1.48, HOM 12mo 1.79±0.29. …”

Triclabendazole decreases intracellular cAMP. by Yong Joo Lee (357685)

Rapamycin decreases Schwann cell markers, whereas statin induces Schwann cell markers. by Andrea Preitschopf (629851)

IκBαM.1-Infected Mice Have Decreased Latency in Lung B Cells 16 dpi after Intranasal Infection by Laurie T Krug (68237)

Silencing of MCT4 decreases cell proliferation. by Jiang Zhu (40858)

Changes of the plasma ET-1 ( pg/mL) concentrations during the oxygen treatment days in the different dignostic newborns tended to decrease by Derya Benzer (43082)

Flowchart of study patients evaluated for cumulative incidence of decreased GFR estimation. by Camila de Souza dos Santos (17721066)

UGGT activity decreases in <i>uggt-1(RNAi)</i> worms but no decrease was observed in <i>uggt-2 (RNAi)</i> worms. by Lucila I. Buzzi (198284)